{"entities": {"annotations": [{"start": 48, "end": 51, "probability": 0.5388, "type": "Organization", "normalized_text": "SARS"}, {"start": 107, "end": 110, "probability": 0.7672, "type": "Organization", "normalized_text": "SARS"}, {"start": 112, "end": 114, "probability": 0.4939, "type": "Organization", "normalized_text": "COV"}]}, "text": "Q5: Who would have developed antibodies against SARS-COV-2/COVID-19?\n A5: Only people who were infected by SARS-COV-2 and had the disease COVID-19 are likely to have developed antibodies against SARS-COV-2/COVID-19.", "reply_settings": "everyone", "in_reply_to_user_id": "53306736", "id": "1252252778249904129", "lang": "en", "possibly_sensitive": false, "referenced_tweets": [{"type": "replied_to", "id": "1252252775523602437"}], "created_at": "2020-04-20T15:08:22.000Z", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "29", "name": "Events [Entity Service]", "description": "Entity Service related Events domain"}, "entity": {"id": "1219057585707315201", "name": "COVID-19: Latest news updates from around the world", "description": "This page is a timeline of Tweets with the latest information and updates on COVID-19 from experts, journalists, health authorities and other trusted sources from around the world. For more on COVID-19, visit: twitter.com/explore/tabs/covid-19"}}], "public_metrics": {"retweet_count": 0, "reply_count": 1, "like_count": 2, "quote_count": 0}, "conversation_id": "1252249440443789313", "author_id": "53306736", "source": "Twitter for Android"}